Title: Pharmaceutical stock price reactions to price constraint threats and firm-level R&D spending
First published: 2005
Subjects: Drugs, Econometric models, Economic aspects, Economic aspects of United States, Law and legislation, Pharmaceutical industry, Prices, Research, United States
Places: United States